Role
The HTA Review Reference Committee will oversee the Health Technology Assessment (HTA) Policy and Methods Review’
The HTA Review Reference Committee will:
- agree the terms of reference for the HTA Review
- agree the expert in HTA to support the HTA Review
- oversee public consultations and considering submissions to the HTA Review
- oversee the analysis undertaken by the expert in HTA
- prepare a final review report and recommendations.
Members
| Member | Role on the Reference Committee |
| Adjunct Professor Debora Picone AO | Independent Chair |
| Ms Ann Single | Patient Representative |
| Dr Dawn Casey PSM | Patient Representative |
| Professor Andrew Wilson | Chair of the Pharmaceutical Benefits Advisory Committee (PBAC) |
| Professor Andrew Roberts AM | Clinical/Scientific Representative |
| Ms Elizabeth de Somer | Member nominated by Medicines Australia |
| Ms Adriana Platona PSM | Government Nominee |
Meetings
The committee holds meetings as needed to meet the 31 December 2023 review deadline.
Agendas
The committee will publish upcoming meeting agendas.
Health Technology Assessment Policy and Methods Review reference committee – Meeting agendas
This collection contains meeting agendas from the Health Technology Assessment Policy and Methods Review reference committee.
Communiques
Health Technology Assessment Policy and Methods Review reference committee – Communiques
This collection contains communiques from the Health Technology Assessment Policy and Methods Review reference committee.
Probity Plan
Health Technology Assessment Review – Probity Plan
The Probity Plan outlines the probity principles and processes agreed by the Reference Committee for the HTA Review.
Contact
HTA Review Secretariat
Contact for the Health Technology Assessment Review
Last updated: